Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/BPO vs Azelaic Acid in Acne Vulgaris
NCT02058628Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- Sep 2014
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin, benzoyl peroxide + sulfur in acne vulgaris, sponsored by GSK. Started Feb 2014; status: completed.
02
Drugs
clindamycinbenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02058628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058628.